Philip Daffas

Philip Daffas

Plus aucun poste en cours

Fortune : 226 529 $ au 30/06/2026

Health Technology
Consumer Services
Commercial Services

Profil

Philip Daffas formerly worked at Applied Physiology Pty Ltd., as Chief Executive Officer, Roche Diagnostics GmbH, as Global Marketing Director, Bio-Rad Laboratories Pty Ltd., as Managing Director, PainChek Ltd., as Managing Director & Non-Executive Director from 2016 to 2026, Cochlear Ltd., as Vice President-Global Marketing, IVAC Corp., as Head-Sales & Marketing, Shiley Infusaid, Inc., as Principal, and Roche Diagnostics Australia Pty Ltd., as General Manager.
Mr. Daffas received his Masters Business Admin degree from Kingston University and undergraduate degree from the University of Westminster.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
06/07/2026 3 114 226 ( 1,49 % ) 226 529 $ 30/06/2026

Anciens postes connus de Philip Daffas

SociétésPosteFin
PAINCHEK LIMITED Directeur Général 06/07/2026
COCHLEAR LIMITED Sales & Marketing 01/01/2002
Bio-Rad Laboratories Pty Ltd.
Corporate Officer/Principal -
Roche Diagnostics Australia Pty Ltd.
Corporate Officer/Principal -
Sales & Marketing -
Voir l'expérience en détail de Philip Daffas

Formation de Philip Daffas

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

20

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées10

Health Technology

Health Technology

Commercial Services

Consumer Services

Consumer Services

Distribution Services

Shiley Infusaid, Inc.

Bio-Rad Laboratories Pty Ltd.

Technology Services

Roche Diagnostics Australia Pty Ltd.

  1. Bourse
  2. Insiders
  3. Philip Daffas
🔇